Glucose-dependent insulinotropic polypeptide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Glucose-dependent insulinotropic polypeptide, covering 2017-06-23 to 2017-06-23. Get the full timeline:
Most recent: Clinical Trial Update: Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes [NA]